Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines , China Pharmaceutical University , 24 Tong Jia Xiang , Nanjing 210009 , People's Republic of China.
J Nat Prod. 2018 May 25;81(5):1148-1153. doi: 10.1021/acs.jnatprod.7b00663. Epub 2018 May 8.
Peyronellones A and B (1 and 2), a pair of rare tetracyclic caged adducts of azaphilone with pyruvic acid, along with four new analogues (3-6), were isolated from solid cultures of the endophytic fungus Peyronellaea glomerata. Their structures were elucidated through spectroscopic analysis, and their absolute configurations were unambiguously determined by a combination of single-crystal X-ray crystallography, Rh(OCOCF)-induced ECD experiments, ECD calculations, and modified Mosher methods. Compound 2 (5 μM) was found to have a significant hypoxia-protective effect that improved the survival rate of hypoxia/reoxygenation-treated human umbilical vein endothelial cells from 35% to 70%, which was equal to the potency of the positive control, verapamil. Flow cytometry analysis suggested 2 could inhibit H/R-induced late-stage apoptosis of this cell line.
佩罗尼洛内 A 和 B(1 和 2)是一对罕见的四环笼状偶氮菲酮与丙酮酸的加合物,以及四个新的类似物(3-6),从内生真菌佩罗尼洛内菌的固体培养物中分离得到。通过光谱分析阐明了它们的结构,并通过单晶 X 射线晶体学、Rh(OCOCF)-诱导的 ECD 实验、ECD 计算和改进的 Mosher 方法的组合,明确确定了它们的绝对构型。发现化合物 2(5 μM)具有显著的缺氧保护作用,可将缺氧/复氧处理的人脐静脉内皮细胞的存活率从 35%提高到 70%,与阳性对照维拉帕米相当。流式细胞术分析表明,2 可以抑制 H/R 诱导的该细胞系晚期凋亡。